Skip to main content
Erschienen in: Rheumatology International 1/2007

01.11.2007 | Case Report

Family history of lymphoma and risk for solid tumors in patients with Sjogren’s syndrome

verfasst von: Zahi Touma, Lina Kibbi, Thurayya Arayssi

Erschienen in: Rheumatology International | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

It has been recognized that primary Sjogren’s syndrome predisposes to the development of lymphoproliferative disorders. However, it is so far uncertain whether these patients are at an increased risk for solid tumors. Herein we report two cases of primary Sjogren’s syndrome complicated by breast and lung cancer and who have a strong family history for lymphoproliferative diseases.
Literatur
1.
Zurück zum Zitat Carsons S (2005) Sjogren’s syndrome. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB (Eds) Kelley’s Textbook of Rheumatology 7th edn. Elsevier, Philadelphia Carsons S (2005) Sjogren’s syndrome. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB (Eds) Kelley’s Textbook of Rheumatology 7th edn. Elsevier, Philadelphia
2.
Zurück zum Zitat Lazarus MN, Robinson D, Mak V, Moller H (2006) Incidence of cancer in a cohort of patients with primary Sjogren’s syndrome. Rheumatology (Oxford) 45:1012–1015CrossRef Lazarus MN, Robinson D, Mak V, Moller H (2006) Incidence of cancer in a cohort of patients with primary Sjogren’s syndrome. Rheumatology (Oxford) 45:1012–1015CrossRef
3.
Zurück zum Zitat Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson L (2006) T Lymphoma and other malignancies in primary Sjogren’s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796–803PubMedCrossRef Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson L (2006) T Lymphoma and other malignancies in primary Sjogren’s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796–803PubMedCrossRef
5.
Zurück zum Zitat Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM (2000) Clinical evolution, and morbidity and mortality of primary Sjogren’s syndrome. Semin Arthritis Rheum 29:296–304PubMedCrossRef Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM (2000) Clinical evolution, and morbidity and mortality of primary Sjogren’s syndrome. Semin Arthritis Rheum 29:296–304PubMedCrossRef
6.
Zurück zum Zitat Sutcliffe N, Inanc M, Speight P, Isenberg D (1998) Predictors of lymphoma development in primary Sjogren’s syndrome. Semin Arthritis Rheum 28:80–87PubMedCrossRef Sutcliffe N, Inanc M, Speight P, Isenberg D (1998) Predictors of lymphoma development in primary Sjogren’s syndrome. Semin Arthritis Rheum 28:80–87PubMedCrossRef
7.
Zurück zum Zitat Naschitz JE (2001) Rheumatic syndromes: clues to occult neoplasia. Curr Opin Rheumatol 13:62–66PubMedCrossRef Naschitz JE (2001) Rheumatic syndromes: clues to occult neoplasia. Curr Opin Rheumatol 13:62–66PubMedCrossRef
8.
Zurück zum Zitat Bernatsky S, Ramsey-Goldman R, Clarke A (2006) Malignancy and autoimmunity. Curr Opin Rheumatol 18:129–134PubMedCrossRef Bernatsky S, Ramsey-Goldman R, Clarke A (2006) Malignancy and autoimmunity. Curr Opin Rheumatol 18:129–134PubMedCrossRef
Metadaten
Titel
Family history of lymphoma and risk for solid tumors in patients with Sjogren’s syndrome
verfasst von
Zahi Touma
Lina Kibbi
Thurayya Arayssi
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 1/2007
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0370-1

Weitere Artikel der Ausgabe 1/2007

Rheumatology International 1/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.